Sionna Therapeutics, Inc. SION
5.23
0.00
0.00%
as of 25 Sep
- Market cap
- $241.9M
- P/E
- 0.0×
Follow SION
| Dec '25 | Dec '24 | Dec '23 | |
|---|---|---|---|
Current Ratio |
20.61 | 14.49 | 4.88 |
Net Debt/EBITDA |
2.58 | 2.02 | 0.76 |
Debt/Assets |
0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | — |
Operating CF/Net income |
0.88 | 0.86 | 0.92 |
Capex/Depreciation |
0.16 | 0.01 | 11.63 |
Interest Coverage |
0.00 | 0.00 | 0.00 |
| (105.18%) | 44.29% | 0.00% | |
| (29.42%) | (51.90%) | 0.00% | |
ROIC |
(78.38%) | 0.00% | 0.00% |
Return on Tangible Assets |
(32.45%) | (43.13%) | (137.89%) |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(1.67) | (13.69) | (15.28) |
Cash per Share |
5.90 | 38.23 | 13.13 |
Shareholders Equity per Share |
7.68 | (42.42) | (39.17) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
7.68 | (42.42) | (39.17) |
Free Cash Flow |
(66.67) | (52.81) | (44.81) |
Working Capital |
229.71 | 140.57 | 31.17 |
Capital Expenditures |
(0.38) | (0.03) | (1.12) |
Net Current Asset Value |
222.30 | (198.47) | (127.62) |
| Other line items | |||
Quick Ratio |
20.14 | 14.16 | 4.79 |
Depreciation/Fixed assets |
(1.08) | (0.95) | (0.03) |
Cash ROIC |
(12.63%) | 341.60% | 61.30% |
Accounts Payable Turnover |
0.00 | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 |
Operating CF per Share |
(1.66) | (13.68) | (14.90) |
Capex per Share |
(0.01) | (0.01) | (0.38) |
Average Payables |
0.98 | 0.95 | — |
Average Assets |
255.85 | 118.85 | — |
Average Common Equity |
71.56 | (139.30) | — |
Capex to Sales |
0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% |
Columns are period end dates